These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 14695341)
1. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Evans AJ; Gallie BL; Jewett MA; Pond GR; Vandezande K; Underwood J; Fradet Y; Lim G; Marrano P; Zielenska M; Squire JA Am J Pathol; 2004 Jan; 164(1):285-93. PubMed ID: 14695341 [TBL] [Abstract][Full Text] [Related]
2. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802 [TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350 [TBL] [Abstract][Full Text] [Related]
4. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109 [TBL] [Abstract][Full Text] [Related]
5. Effects of degenerate oligonucleotide-primed polymerase chain reaction amplification and labeling methods on the sensitivity and specificity of metaphase- and array-based comparative genomic hybridization. Tsubosa Y; Sugihara H; Mukaisho K; Kamitani S; Peng DF; Ling ZQ; Tani T; Hattori T Cancer Genet Cytogenet; 2005 Apr; 158(2):156-66. PubMed ID: 15796963 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis of 6p22 genomic gain in retinoblastoma. Orlic M; Spencer CE; Wang L; Gallie BL Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235 [TBL] [Abstract][Full Text] [Related]
8. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Veltman JA; Fridlyand J; Pejavar S; Olshen AB; Korkola JE; DeVries S; Carroll P; Kuo WL; Pinkel D; Albertson D; Cordon-Cardo C; Jain AN; Waldman FM Cancer Res; 2003 Jun; 63(11):2872-80. PubMed ID: 12782593 [TBL] [Abstract][Full Text] [Related]
9. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555 [TBL] [Abstract][Full Text] [Related]
10. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma. Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284 [TBL] [Abstract][Full Text] [Related]
11. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Pinkel D; Segraves R; Sudar D; Clark S; Poole I; Kowbel D; Collins C; Kuo WL; Chen C; Zhai Y; Dairkee SH; Ljung BM; Gray JW; Albertson DG Nat Genet; 1998 Oct; 20(2):207-11. PubMed ID: 9771718 [TBL] [Abstract][Full Text] [Related]
12. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480 [TBL] [Abstract][Full Text] [Related]
13. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade. Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469 [TBL] [Abstract][Full Text] [Related]
14. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936 [TBL] [Abstract][Full Text] [Related]
15. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study. Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070 [TBL] [Abstract][Full Text] [Related]
16. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835 [TBL] [Abstract][Full Text] [Related]
17. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis? Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674 [TBL] [Abstract][Full Text] [Related]
18. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström PU Anticancer Res; 1999; 19(1A):7-12. PubMed ID: 10226518 [TBL] [Abstract][Full Text] [Related]
19. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865 [TBL] [Abstract][Full Text] [Related]
20. Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Gorringe KL; Boussioutas A; Bowtell DD; Genes Chromosomes Cancer; 2005 Mar; 42(3):247-59. PubMed ID: 15611932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]